PlainRecalls
FDA Drug Moderate Class II Ongoing

Buprenorphine Hydrochloride Injection, 0.3 mg base/mL, 1 mL Single-dose Carpuject, Sterile Cartridge Unit with Luer Lock, For Intramuscular or Intravenous Use, Rx Only, Distributed by Hospira, Inc., Lake Forest, IL 60045 USA. NDC: 0409-2012-03

Reported: July 3, 2024 Initiated: May 20, 2024 #D-0564-2024

Product Description

Buprenorphine Hydrochloride Injection, 0.3 mg base/mL, 1 mL Single-dose Carpuject, Sterile Cartridge Unit with Luer Lock, For Intramuscular or Intravenous Use, Rx Only, Distributed by Hospira, Inc., Lake Forest, IL 60045 USA. NDC: 0409-2012-03

Reason for Recall

Lack of Assurance of Sterility-The potential for incomplete crimp seals.

Details

Recalling Firm
Pfizer Inc.
Units Affected
84,710 cartridges
Distribution
US Nationwide and Puerto Rico.
Location
New York, NY

Frequently Asked Questions

What product was recalled?
Buprenorphine Hydrochloride Injection, 0.3 mg base/mL, 1 mL Single-dose Carpuject, Sterile Cartridge Unit with Luer Lock, For Intramuscular or Intravenous Use, Rx Only, Distributed by Hospira, Inc., Lake Forest, IL 60045 USA. NDC: 0409-2012-03. Recalled by Pfizer Inc.. Units affected: 84,710 cartridges.
Why was this product recalled?
Lack of Assurance of Sterility-The potential for incomplete crimp seals.
Which agency issued this recall?
This recall was issued by the FDA Drug on July 3, 2024. Severity: Moderate. Recall number: D-0564-2024.